Wednesday, July 29, 2020

Sanofi, GSK to supply up to 60 million doses of COVID-19 vaccine to UK

Sanofi, GSK to supply up to 60 million doses of COVID-19 vaccine to UK Financial terms of the agreement were not disclosed. Sanofi and GSK, which had first teamed up in April, confirmed in a statement that regulatory approval for their vaccine could be achieved by the first half of 2021 if clinical data was to be positive.

from Moneycontrol Business News https://ift.tt/334BuWM
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

US stock: S&P 500 ends lower as investors weigh data, Middle East tensions

The S&P 500's streak came to an end, falling from its peak as weaker retail sales suggested caution among consumers. Despite a stron...